ES8506092A1 - Un metodo de producir un precursor del factor de liberacion de la hormona del crecimiento humana - Google Patents

Un metodo de producir un precursor del factor de liberacion de la hormona del crecimiento humana

Info

Publication number
ES8506092A1
ES8506092A1 ES534002A ES534002A ES8506092A1 ES 8506092 A1 ES8506092 A1 ES 8506092A1 ES 534002 A ES534002 A ES 534002A ES 534002 A ES534002 A ES 534002A ES 8506092 A1 ES8506092 A1 ES 8506092A1
Authority
ES
Spain
Prior art keywords
precursor
host cells
dna encoding
grfh
way
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES534002A
Other languages
English (en)
Other versions
ES534002A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salk Institute for Biological Studies
Original Assignee
Salk Institute for Biological Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Institute for Biological Studies filed Critical Salk Institute for Biological Studies
Publication of ES8506092A1 publication Critical patent/ES8506092A1/es
Publication of ES534002A0 publication Critical patent/ES534002A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCEDIMIENTO PARA LA PRODUCCION DE UN PRECURSOR DEL FACTOR DE LIBERACION DE LA HORMONA DEL CRECIMIENTO HUMANO.COMPRENDEE LAS SIGUIENTES OPERACIONES: PRIMERA, SE PROPORCIONA UNA SECUENCIA DE ADN QUE TIENE CODIFICADO UN POLIPEPTIDO PRECURSOR DE GRFH CON UNA SECUENCIA DE AMINOACIDOS DE FORMULA (I); SEGUNDA, SE TRANSFORMAN LAS CELULAS HOSPEDADORAS CON DICHA SECUENCIA DE ADN, DE TAL MANERA QUE DICHAS CELULAS HOSPEDADORAS EXPRESEN EL POLIPEPTIDO CODIFICADO; Y POR ULTIMO, SE CULTIVAN DICHAS CELULAS HOSPEDADORAS DE TAL MANERA QUE SE EXPRESE EL POLIPEPTIDO PRECURSOR DE GRFH.
ES534002A 1983-07-05 1984-07-04 Un metodo de producir un precursor del factor de liberacion de la hormona del crecimiento humana Granted ES534002A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51093583A 1983-07-05 1983-07-05

Publications (2)

Publication Number Publication Date
ES8506092A1 true ES8506092A1 (es) 1985-06-16
ES534002A0 ES534002A0 (es) 1985-06-16

Family

ID=24032800

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534002A Granted ES534002A0 (es) 1983-07-05 1984-07-04 Un metodo de producir un precursor del factor de liberacion de la hormona del crecimiento humana

Country Status (17)

Country Link
EP (1) EP0134085A1 (es)
JP (1) JP2506322B2 (es)
KR (1) KR850001281A (es)
AU (1) AU571542B2 (es)
CA (1) CA1299119C (es)
DK (1) DK313784A (es)
ES (1) ES534002A0 (es)
FI (1) FI81378C (es)
GR (1) GR82239B (es)
HU (1) HU197939B (es)
IL (1) IL72299A (es)
MX (1) MX167047B (es)
NO (1) NO842682L (es)
NZ (1) NZ208633A (es)
PH (1) PH22584A (es)
PT (1) PT78833B (es)
ZA (1) ZA844380B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3327007A1 (de) * 1983-07-27 1985-02-07 Hoechst Ag, 6230 Frankfurt Herstellung von polypeptiden mit einem saeureamid-carboxyterminus
NZ213759A (en) * 1984-10-19 1989-01-27 Genentech Inc Lhrh-ctp protein conjugates influencing prolactin fsh and lh release
US4828988A (en) * 1986-05-15 1989-05-09 Smith Kline - Rit Hybrid polypeptides comprising somatocrinine and alpha1 -antitrypsin, method for their production from bacterial clones and use thereof for the production of somatocrinine
JPS63123386A (ja) * 1986-11-14 1988-05-27 Japan Tobacco Inc 植物ウイルス阻害物質の製造方法
NZ242344A (en) * 1991-04-19 1993-11-25 Lilly Co Eli Dna encoding bovine growth hormone releasing factor and precursors, the polypeptide precursor and pharmaceutical compositions
US5512459A (en) * 1993-07-20 1996-04-30 Bionebraska, Inc. Enzymatic method for modification or recombinant polypeptides
CA2297375A1 (en) 1997-07-24 1999-02-04 Valentis, Inc. Ghrh expression system and methods of use
DE602005027661D1 (de) * 2004-01-20 2011-06-09 VGX Pharmaceuticals LLC Isetzendem hormon (ghrh) aus muskelzellen durch speziesspezifisches signalpeptid
KR102461139B1 (ko) * 2020-01-22 2022-11-01 태경에코 주식회사 대기오염물질의 배출저감 연탄 및 그의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA802992B (en) * 1979-06-01 1981-10-28 Univ California Human pre-growth hormone
US4563352A (en) * 1982-10-04 1986-01-07 The Salk Institute For Biological Studies Human pancreatic GRF
DE3381567D1 (de) * 1982-11-04 1990-06-21 Hoffmann La Roche Hestellung von rekombinanten wachstumsausloesenden faktoren.

Also Published As

Publication number Publication date
PT78833A (en) 1984-08-01
PT78833B (en) 1986-06-02
DK313784D0 (da) 1984-06-27
HU197939B (en) 1989-06-28
CA1299119C (en) 1992-04-21
FI81378B (fi) 1990-06-29
NO842682L (no) 1985-01-07
JPS6037990A (ja) 1985-02-27
JP2506322B2 (ja) 1996-06-12
FI81378C (fi) 1990-10-10
EP0134085A1 (en) 1985-03-13
FI842664L (fi) 1985-01-06
KR850001281A (ko) 1985-03-18
NZ208633A (en) 1987-09-30
AU2973384A (en) 1985-01-10
ES534002A0 (es) 1985-06-16
AU571542B2 (en) 1988-04-21
GR82239B (es) 1984-12-13
IL72299A (en) 1990-12-23
ZA844380B (en) 1985-01-30
PH22584A (en) 1988-10-17
HUT35009A (en) 1985-05-28
FI842664A0 (fi) 1984-07-02
IL72299A0 (en) 1984-11-30
DK313784A (da) 1985-01-06
MX167047B (es) 1993-02-26

Similar Documents

Publication Publication Date Title
AU630951B2 (en) Enzymatic removal of a protein amino-terminal sequence
AU595290B2 (en) Process for producing human epidermal growth factor and analogs thereof
NO174351C (no) Fremgangsmåte for fremstilling av human insulinforlöper samt DNA-sekvens og vektor til anvendelse av fremgangsmåten
ES2056817T3 (es) Transformacion de trichoderma.
DE3752319D1 (de) Prozess zur rekombinanten Herstellung von HIV-2 - Proteinen sowie Zellen, die HIV-2 - Proteine exprimiert
DK521283A (da) Middel til kosmetisk hudpleje og fremgangsmaade til dets fremstilling
GB2197324B (en) Process for the production of a polypeptide
AR241314A1 (es) Aislado de adn, vector en base en dicho aislado cultivo de celulas tratadas con dicho vector y preparacion de factor viii humano funcional.
ES8507179A1 (es) Un metodo de conseguir una deseada proteina madura en una celula hospedante de vertebrado.
AR017510A1 (es) Polinucleotido aislado o recombinante, vector de expresion, celula huesped, metodo para preparar un polipeptido antigenico, metodo y equipo para ladeteccion de un polinucleotido, compuesto de union, metodo de empleo del compuesto de union, polipeptido antigenico aislado o substancialmente puro, ymet
NO167295C (no) Fremgangsmaate for fremstilling av et terapeutisk aktivt peptid.
DE3878231D1 (de) Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.
EP0218531A3 (en) Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies
ATE63750T1 (de) Peptid, dessen herstellung und benutzung.
MY102257A (en) Production and use of a novel t-cell suppressor factor
EP0236978A3 (en) Production of factor xiiia by gene technology
KR850001287A (ko) 폴리펩타이드의 제조방법
ES2061619T3 (es) Metodo mejorado para la preparacion de la hormona de crecimiento humano natural en forma pura.
EP0315118A3 (en) Dna coding for endothelin and use thereof
ES2061524T3 (es) Un vector plasmidico para la expresion en bacillus y empleado para la clonacion del gen estructural que codifica la hormona de crecimiento humana y un metodo para la produccion de la hormona.
JPS5775960A (en) Purified polypeptide
NO921489L (no) Forloeperformer av bovin veksthormon-frigjoerende faktor ogbeslektede dna-forbindelser
ATE110112T1 (de) Verfahren und systeme zur herstellung von hiv- antigenen.
ATE49401T1 (de) Verfahren zur herstellung von alkylarylethern.
ATE91303T1 (de) Verfahren zur herstellung von peptiden durch spezifische spaltung von gentechnisch gewonnenen fusionsproteinen mit collagenasen.